DNA診断市場の成長と動向分析レポート

DNA Diagnostics Market Growth & Trends

The global DNA diagnostics market size is expected to reach a value of USD 14.14 billion in 2030 and is projected to grow at a CAGR of 4.51% from 2024 to 2030, according to a new report by Grand View Research, Inc.

世界のDNA診断市場規模は2030年に141億4,000万米ドルに達すると予想されており、2024年から2030年まで4.51%のCAGRで成長すると予測されています。

The growth of the market is due to advancements in genome sequencing and the development of personalized DNA-level diagnostic applications. In addition, the rising number of government-sponsored patented research initiatives and funded projects are anticipated to further drive demand in the market. For instance, in December 2022, the UK government announced a funding of USD 229.4 (£175) million for the development and creation of advanced genomic research.

The market growth is highly driven by the introduction of novel technologies for genome profiling. Moreover, with the increasing incidence of chronic oncology and infectious diseases that rely on DNA prototyping for treatment and diagnosis through personalized medicine, the demand for DNA diagnostics/testing-based research is anticipated to increase significantly over the forecast period. Furthermore, the increasing demand for DNA diagnostics/testing is driven by the rising demand for prenatal testing, and in-vitro fertilization is expected to provide positive growth prospects to the market. In September 2022, Eurofins Genoma announced the launch of niPGT-A, an embryo-free, non-invasive preimplantation screening test.

DNA diagnostics enables the comprehensive analysis of tumor genomes through techniques such as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes, providing a detailed view of the genetic alterations present in the tumor. By comparing the tumor genome with normal tissue DNA, scientists and clinicians can identify specific mutations, copy number variations, and structural rearrangements unique to the cancer cells. In June 2022, Illumina, a DNA sequencing and array-based technology provider, introduces a research test developed in collaboration with Merck, aimed at unlocking deeper insights into the tumor genome.

DNA Diagnostics Market Report Scope

Hepatitis C virus (HCV) is a global health concern, affecting millions of people worldwide. Accurate and timely diagnosis of HCV is crucial for effective treatment and prevention of further transmission. In this context, DNA diagnostics has emerged as a powerful tool for detecting and managing HCV infections. In July 2022, Roche introduced a groundbreaking dual antigen and antibody diagnostic test Elecsys HCV Duo, to aid the global efforts in eradicating the hepatitis C virus.

DNA Diagnostics Market Report Highlights

• The PCR-based diagnostics segment held the largest share of 50.36% in 2023, the dominance of this segment can be attributed to the widespread market usage and the increase in product availability due to the rising number of key players introducing innovative PCR-based diagnostics

• NGS DNA diagnosis is projected to grow fastest CAGR of 9.65% over the forecast period owing to advancements in high-throughput sequencing technologies that enable comprehensive genetic analyses.

• Cancer genetics tests segment held the largest share of 29.47% in 2023. DNA sequencing technologies are increasingly utilized to identify and characterize various cancer types and genetic disorders.

• North America DNA diagnostics market dominated the overall global market and accounted for the 43.20 %revenue share in 2023.

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Segment Definitions

1.2.1. Technology

1.2.2. Application

1.2.3. Regional Scope

1.2.4. Estimates and forecasts timeline

1.3. Research Methodology

1.4. Information Procurement

1.4.1. Purchased database

1.4.2. GVR’s internal database

1.4.3. Secondary sources

1.4.4. Primary research

1.4.5. Details of primary research

1.5. Information or Data Analysis

1.5.1. Data analysis models

1.6. Market Formulation & Validation

1.7. Model Details

1.7.1. Commodity flow analysis (Model 1)

1.7.2. Approach 1: Commodity flow approach

1.7.3. Volume price analysis (Model 2)

1.7.4. Approach 2: Volume price analysis

1.8. List of Secondary Sources

1.9. List of Primary Sources

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Technology outlook

2.2.2. Application outlook

2.3. Regional outlook

2.4. Competitive Insights

Chapter 3. DNA Diagnostics Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.3. DNA Diagnostics Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Bargaining power of suppliers

3.3.1.2. Bargaining power of buyers

3.3.1.3. Threat of substitutes

3.3.1.4. Threat of new entrants

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Economic landscape

3.3.2.3. Social landscape

3.3.2.4. Technological landscape

3.3.2.5. Environmental landscape

3.3.2.6. Legal landscape

Chapter 4. DNA Diagnostics Market: Technology Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. DNA Diagnostics Market: Technology Movement Analysis

4.3. DNA Diagnostics Market by Technology Outlook (USD Billion)

4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

4.5. PCR-based Diagnostics

4.5.1. PCR-based Diagnostics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

4.6. NGS DNA Diagnosis

4.6.1. NGS DNA Diagnosis Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

4.7. In-Situ Hybridization Diagnostics

4.7.1. In-Situ Hybridization Diagnostics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

4.8. Microarrays-based Diagnostics

4.8.1. Microarrays-based Diagnostics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

4.9. Other Technologies

4.9.1. In Other Technologies Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

Chapter 5. DNA Diagnostics Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. DNA Diagnostics Market: Application Movement Analysis

5.3. DNA Diagnostics Market by Application Outlook (USD Billion)

5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

5.5. Cancer Genetics Tests

5.5.1. Cancer Genetics Tests Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.6. Infectious Diseases DNA Testing

5.6.1. Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.6.2. HBV Diagnostic

5.6.2.1. HBV Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.6.3. TB Diagnostic

5.6.3.1. TB Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.6.4. CT/NG Diagnostic

5.6.4.1. CT/NG Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.6.5. HPV Diagnostic

5.6.5.1. HPV Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.6.6. MRSA Diagnostic

5.6.6.1. MRSA Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.6.7. Others

5.6.7.1. Others Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.7. Newborn Genetic Screening

5.7.1. Newborn Genetic Screening Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.8. Preimplantation & Reproductive Diagnosis

5.8.1. Preimplantation & Reproductive Diagnosis Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.9. Non-Infectious Diseases DNA Testing

5.9.1. Non-Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.9.2. Cardiovascular Diseases

5.9.2.1. Cardiovascular Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.9.3. CNS & PNS Related

5.9.3.1. CNS & PNS Related Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.9.4. Skeletal, Connective, Ectodermal & Dermal DNA Testing

5.9.4.1. Skeletal, Connective, Ectodermal & Dermal DNA Testing Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.9.5. Lung, Kidney, Liver & GT Related

5.9.5.1. Lung, Kidney, Liver & GT Related Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.9.6. Sensory Diseases

5.9.6.1. Sensory Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.10. Prenatal DNA Carrier Screening

5.10.1. Prenatal DNA Carrier Screening Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.11. Pharmacogenomics/Drug Metabolism

5.11.1. Pharmacogenomics/Drug Metabolism Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.12. Hematology & Immunology/Identity Diagnostics & Forensics

5.12.1. Hematology & Immunology/Identity Diagnostics & Forensics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

5.13. Others

5.13.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)

Chapter 6. DNA Diagnostics Market: Regional Estimates & Trend Analysis

6.1. Regional Dashboard

6.2. Regional DNA Diagnostics Market movement analysis

6.3. DNA Diagnostics Market: Regional Estimates & Trend Analysis by Technology, Biomaterial & End-use

6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

6.5. North America

6.5.1. North America DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.5.2. U.S.

6.5.2.1. U.S. DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.5.2.2. Key Country Dynamics

6.5.2.3. Regulatory Framework

6.5.2.4. Reimbursement Scenario

6.5.2.5. Competitive Scenario

6.5.3. Canada

6.5.3.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.5.3.2. Key Country Dynamics

6.5.3.3. Regulatory Framework

6.5.3.4. Reimbursement Scenario

6.5.3.5. Competitive Scenario

6.5.4. Mexico

6.5.4.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.5.4.2. Key Country Dynamics

6.5.4.3. Regulatory Framework

6.5.4.4. Reimbursement Scenario

6.5.4.5. Competitive Scenario

6.6. Europe

6.6.1. Europe DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.2. UK

6.6.2.1. UK DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.2.2. Key Country Dynamics

6.6.2.3. Regulatory Framework

6.6.2.4. Reimbursement Scenario

6.6.2.5. Competitive Scenario

6.6.3. Germany

6.6.3.1. Germany DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.3.2. Key Country Dynamics

6.6.3.3. Regulatory Framework

6.6.3.4. Reimbursement Scenario

6.6.3.5. Competitive Scenario

6.6.4. France

6.6.4.1. France DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.4.2. Key Country Dynamics

6.6.4.3. Regulatory Framework

6.6.4.4. Reimbursement Scenario

6.6.4.5. Competitive Scenario

6.6.5. Italy

6.6.5.1. Italy DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.5.2. Key Country Dynamics

6.6.5.3. Regulatory Framework

6.6.5.4. Reimbursement Scenario

6.6.5.5. Competitive Scenario

6.6.6. Spain

6.6.6.1. Spain DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.6.2. Key Country Dynamics

6.6.6.3. Regulatory Framework

6.6.6.4. Reimbursement Scenario

6.6.6.5. Competitive Scenario

6.6.7. Denmark

6.6.7.1. Denmark DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.7.2. Key Country Dynamics

6.6.7.3. Regulatory Framework

6.6.7.4. Reimbursement Scenario

6.6.7.5. Competitive Scenario

6.6.8. Norway

6.6.8.1. Norway DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.8.2. Key Country Dynamics

6.6.8.3. Regulatory Framework

6.6.8.4. Reimbursement Scenario

6.6.8.5. Competitive Scenario

6.6.9. Sweden

6.6.9.1. Sweden DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.6.9.2. Key Country Dynamics

6.6.9.3. Regulatory Framework

6.6.9.4. Reimbursement Scenario

6.6.9.5. Competitive Scenario

6.7. Asia Pacific

6.7.1. Asia Pacific DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.7.2. Japan

6.7.2.1. Japan DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.7.2.2. Key Country Dynamics

6.7.2.3. Regulatory Framework

6.7.2.4. Reimbursement Scenario

6.7.2.5. Competitive Scenario

6.7.3. China

6.7.3.1. China DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.7.3.2. Key Country Dynamics

6.7.3.3. Regulatory Framework

6.7.3.4. Reimbursement Scenario

6.7.3.5. Competitive Scenario

6.7.4. India

6.7.4.1. India DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.7.4.2. Key Country Dynamics

6.7.4.3. Regulatory Framework

6.7.4.4. Reimbursement Scenario

6.7.4.5. Competitive Scenario

6.7.5. South Korea

6.7.5.1. South Korea DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.7.5.2. Key Country Dynamics

6.7.5.3. Regulatory Framework

6.7.5.4. Reimbursement Scenario

6.7.5.5. Competitive Scenario

6.7.6. Australia

6.7.6.1. Australia DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.7.6.2. Key Country Dynamics

6.7.6.3. Regulatory Framework

6.7.6.4. Reimbursement Scenario

6.7.6.5. Competitive Scenario

6.7.7. Thailand

6.7.7.1. Thailand DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.7.7.2. Key Country Dynamics

6.7.7.3. Regulatory Framework

6.7.7.4. Reimbursement Scenario

6.7.7.5. Competitive Scenario

6.8. Latin America

6.8.1. Latin America DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.8.2. Brazil

6.8.2.1. Brazil DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.8.2.2. Key Country Dynamics

6.8.2.3. Regulatory Framework

6.8.2.4. Reimbursement Scenario

6.8.2.5. Competitive Scenario

6.8.3. Argentina

6.8.3.1. Argentina DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.8.3.2. Key Country Dynamics

6.8.3.3. Regulatory Framework

6.8.3.4. Reimbursement Scenario

6.8.3.5. Competitive Scenario

6.9. Middle East & Africa

6.9.1. Middle East & Africa DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.9.2. South Africa

6.9.2.1. South Africa DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.9.2.2. Key Country Dynamics

6.9.2.3. Regulatory Framework

6.9.2.4. Reimbursement Scenario

6.9.2.5. Competitive Scenario

6.9.3. Saudi Arabia

6.9.3.1. Saudi Arabia DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.9.3.2. Key Country Dynamics

6.9.3.3. Regulatory Framework

6.9.3.4. Reimbursement Scenario

6.9.3.5. Competitive Scenario

6.9.4. UAE

6.9.4.1. UAE DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.9.4.2. Key Country Dynamics

6.9.4.3. Regulatory Framework

6.9.4.4. Reimbursement Scenario

6.9.4.5. Competitive Scenario

6.9.5. Kuwait

6.9.5.1. Kuwait DNA Diagnostics Market Estimates and Forecasts, 2018 – 2030 (USD Billion)

6.9.5.2. Key Country Dynamics

6.9.5.3. Regulatory Framework

6.9.5.4. Reimbursement Scenario

6.9.5.5. Competitive Scenario

Chapter 7. Competitive Landscape

7.1. Market Participant Categorization

7.2. Company Categorization

7.3. Strategy Mapping

7.3.1. NEW PRODUCT LAUNCH

7.3.2. PARTNERSHIPS

7.3.3. ACQUISITION

7.3.4. COLLABORATION

7.4. Key Company Market Share Analysis, 2023

7.5. Key Company Profiles

7.5.1. Abbott

7.5.1.1. Company overview

7.5.1.2. Financial performance

7.5.1.3. Technology benchmarking

7.5.1.4. Strategic initiatives

7.5.2. F. Hoffmann-La Roche Ltd.

7.5.2.1. Company overview

7.5.2.2. Financial performance

7.5.2.3. Technology benchmarking

7.5.2.4. Strategic initiatives

7.5.3. QIAGEN

7.5.3.1. Company overview

7.5.3.2. Financial performance

7.5.3.3. Technology benchmarking

7.5.3.4. Strategic initiatives

7.5.4. Bio-Rad Laboratories, Inc.

7.5.4.1. Company overview

7.5.4.2. Financial performance

7.5.4.3. Technology benchmarking

7.5.4.4. Strategic initiatives

7.5.5. Thermo Fisher Scientific, Inc.

7.5.5.1. Company overview

7.5.5.2. Financial performance

7.5.5.3. Technology benchmarking

7.5.5.4. Strategic initiatives

7.5.6. Illumina, Inc.

7.5.6.1. Company overview

7.5.6.2. Financial performance

7.5.6.3. Technology benchmarking

7.5.6.4. Strategic initiatives

7.5.7. Hologic, Inc.

7.5.7.1. Company overview

7.5.7.2. Financial performance

7.5.7.3. Technology benchmarking

7.5.7.4. Strategic initiatives

7.5.8. Agilent Technologies Inc.

7.5.8.1. Company overview

7.5.8.2. Financial performance

7.5.8.3. Technology benchmarking

7.5.8.4. Strategic initiatives

7.5.9. Siemens Healthineers AG

7.5.9.1. Company overview

7.5.9.2. Financial performance

7.5.9.3. Technology benchmarking

7.5.9.4. Strategic initiatives

7.5.10. Danaher Corporation

7.5.10.1. Company overview

7.5.10.2. Financial performance

7.5.10.3. Technology benchmarking

7.5.10.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources

Table 2 List of Abbreviations

Table 3 Global DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 4 Global DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 5 North America DNA diagnostics market, by region, 2018 – 2030 (USD Billion)

Table 6 North America DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 7 North America DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 8 U.S. DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 9 U.S. DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 10 Canada DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 11 Canada DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 12 Mexico DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 13 Mexico DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 14 Europe DNA diagnostics market, by country, 2018 – 2030 (USD Billion)

Table 15 Europe DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 16 Europe DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 17 UK DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 18 UK DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 19 Germany DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 20 Germany DNA diagnostics market, by application 2018 – 2030 (USD Billion)

Table 21 France DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 22 France DNA diagnostics market, by application 2018 – 2030 (USD Billion)

Table 23 Italy DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 24 Italy DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 25 Spain DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 26 Spain DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 27 Denmark DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 28 Denmark DNA diagnostics market, by application 2018 – 2030 (USD Billion)

Table 29 Norway DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 30 Norway DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 31 Sweden DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 32 Sweden DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 33 Asia Pacific DNA diagnostics market, by country, 2018 – 2030 (USD Billion)

Table 34 Asia Pacific DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 35 Asia Pacific DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 36 Japan DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 37 Japan DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 38 China DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 39 China DNA diagnostics market, by application 2018 – 2030 (USD Billion)

Table 40 India DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 41 India DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 42 Australia DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 43 Australia DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 44 South Korea DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 45 South Korea DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 46 Thailand DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 47 Thailand DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 48 Latin America DNA diagnostics market, by country, 2018 – 2030 (USD Billion)

Table 49 Latin America DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 50 Latin America DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 51 Brazil DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 52 Brazil DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 53 Argentina DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 54 Argentina DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 55 Middle East & Africa DNA diagnostics market, by country, 2018 – 2030 (USD Billion)

Table 56 Middle East & Africa DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 57 Middle East & Africa DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 58 South Africa DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 59 South Africa DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 60 Saudi Arabia DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 61 Saudi Arabia DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 62 UAE DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 63 UAE DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

Table 64 Kuwait DNA diagnostics market, by technology, 2018 – 2030 (USD Billion)

Table 65 Kuwait DNA diagnostics market, by application, 2018 – 2030 (USD Billion)

List of Figures

Fig. 1 DNA diagnostics market segmentation

Fig. 2 Market research process

Fig. 3 Data triangulation techniques

Fig. 4 Primary research pattern

Fig. 5 Value chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Market snapshot

Fig. 9 Technology snapshot

Fig. 10 Application snapshot

Fig. 11 Competitive landscape snapshot

Fig. 12 Parent market value, 2023 (USD Billion)

Fig. 13 Market dynamics

Fig. 14 Porter’s five forces analysis

Fig. 15 PESTLE analysis

Fig. 16 DNA diagnostics market: Technology outlook and key takeaways

Fig. 17 DNA diagnostics market: Technology movement analysis

Fig. 18 PCR-based diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 19 Microarrays-based diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 20 In-situ hybridization diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 21 NGS DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 22 Other technologies market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 23 DNA diagnostics market: Application outlook and key takeaways

Fig. 24 DNA diagnostics market: Application movement analysis

Fig. 25 Cancer genetics tests market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 26 Infectious diseases DNA testing market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 27 HBV diagnostic market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 28 TB diagnostic market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 29 CT/NG diagnostic market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 30 HPV diagnostic market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 31 MRSA diagnostic market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 32 Other infectious diseases DNA testing market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 33 Newborn genetic screening market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 34 Preimplantation & reproductive diagnosis market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 35 Non-infectious diseases DNA testing market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 36 Cardiovascular diseases diagnostic market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 37 CNS & PNS related market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 38 Skeletal, connective, ectodermal & dermal DNA testing market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 39 Lung, kidney, liver & GT related market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 40 Sensory diseases market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 41 Prenatal DNA carrier screening market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 42 Pharmacogenomics/drug metabolism market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 43 Hematology & immunology/identity diagnostics & forensics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 44 Other applications market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 45 DNA diagnostics market revenue, by region, 2023 & 2030 (USD Million)

Fig. 46 Regional marketplace: Key takeaways

Fig. 47 Regional marketplace: Key takeaways

Fig. 48 North America DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 49 Key country dynamics

Fig. 50 U.S. DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 51 Key country dynamics

Fig. 52 Canada DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 53 Key country dynamics

Fig. 54 Mexico DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 55 Europe DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 56 Key country dynamics

Fig. 57 UK DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 58 Key country dynamics

Fig. 59 Germany DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 60 Key country dynamics

Fig. 61 France DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 62 Key country dynamics

Fig. 63 Spain DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 64 Key country dynamics

Fig. 65 Italy DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 66 Key country dynamics

Fig. 67 Denmark DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 68 Key country dynamics

Fig. 69 Sweden DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 70 Key country dynamics

Fig. 71 Norway DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 72 Rest of Europe DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 73 Asia Pacific DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 74 Key country dynamics

Fig. 75 Japan DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 76 Key country dynamics

Fig. 77 China DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 78 China regulatory details

Fig. 79 Key country dynamics

Fig. 80 India DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 81 Key country dynamics

Fig. 82 Australia DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 83 Key country dynamics

Fig. 84 Thailand DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 85 Key country dynamics

Fig. 86 South Korea DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 87 South Korean regulations in four hierarchical orders

Fig. 88 Rest of Asia Pacific DNA diagnostics market estimates and forecast, 2018 – 2030 (USD Million)

Fig. 89 Latin America DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 90 Key country dynamics

Fig. 91 Brazil DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 92 Key country dynamics

Fig. 93 Argentina DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 94 Rest of Latin America DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 95 MEA DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 96 Key country dynamics

Fig. 97 South Africa DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 98 Key country dynamics

Fig. 99 Saudi Arabia DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 100 Key country dynamics

Fig. 101 UAE DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 102 Key country dynamics

Fig. 103 Kuwait DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 104 Rest of MEA DNA diagnostics market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 105 Key company categorization

Fig. 106 Heat map analysis

Fig. 107 Strategic framework

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• CVDおよびCVI真空炉市場規模、成長と動向分析レポート 2025-2030年
• 代替乳製品市場規模、成長と動向分析レポート 2025-2030年
• チラー市場規模、成長と動向分析レポート 2025-2030年
• コアバンキングソフトウェア市場規模、成長と動向分析レポート 2025-2030年
• オフハイウェイ車両照明市場規模、成長と動向分析レポート 2025-2030年

出版レポート一覧